Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Shared Decision Making in Cancer Treatment: Findings from a Large Survey of Lymphoma (LYM) Patients and Survivors

Kendall H Sullivan, PharmD, Michael Toscani, PharmD, Tayla Poretta, PharmD, Ciera Patzke, PharmD, BCOP, Thushara Korattyil, PharmD, Denalee O'Malley, PhD MSW, Victor Gonzalez, MA, MS, Joseph Barone, PharmD, Andrew M. Evens, DO,MSc

Blood (2019) 134 (Supplement_1): 2134.

https://doi.org/10.1182/blood-2019-123459

Published: 2019

Journal Articles

Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)

Nathan Radakovich, BA, Mikkael A. Sekeres, MD MS, Cameron Beau Hilton, BA, Sudipto Mukherjee, MD PhD MPH, Jacob Shreve, MD MS, Yazan Rouphail, Rachel Shirley, Vera Adema, PhD, Hassan Awada, MD, Anjali S. Advani, MD, Cassandra M Kerr, MS, Yasunobu Nagata, MD PhD, Yihong Guan, PhD, Teodora Kuzmanovic, BA, Metis Hasipek, PhD, Babal K. Jha, PhD, Jaroslaw P. Maciejewski, MD PhD, Aziz Nazha, MD

Blood (2019) 134 (Supplement_1): 2089.

https://doi.org/10.1182/blood-2019-126275

Published: 2019

Journal Articles

Voice of Cancer Patients: Patient Experience Regarding Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Sangeeta Aggarwal, MD, Singh Manish, B.Tech, Guroosh Chaudhary, Alok Aggarwal, PhD, Himanshu Punetha, M. Tech, Juhi Jha, Rahul Kumar Gond

Blood (2019) 134 (Supplement_1): 5843.

https://doi.org/10.1182/blood-2019-125195

Published: 2019

Journal Articles

Voice of Cancer Patients (VoCP): Analysis of Patient Experiences and Use of Burton's Tyrosine Kinase (BTK) Inhibitors and Venetoclax in Hematological Malignancies

Sangeeta Aggarwal, MD, Alok Aggarwal, PhD, Jyoti Bhowmick, M.B.A., Rishi Sharma, B.Tech, Rahul Gond, Siddhant Kapoor, B.Tech, Sujeet Kumar, B.Tech

Blood (2018) 132 (Supplement 1): 3582.

https://doi.org/10.1182/blood-2018-99-119727

Published: 2018

Journal Articles

Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017

Marjorie E Zettler, PhD MPH, Ethan Basch, MD MSc, Chadi Nabhan, MD

Blood (2018) 132 (Supplement 1): 2292.

https://doi.org/10.1182/blood-2018-99-116404

Published: 2018

Journal Articles

"in the Patients' Hands"- a Structured Survey of Patient Voices to Prioritise Research Questions in Rare Inherited Anaemias: The James Lind Alliance Priority Setting Partnership

Jenny Welch, Nick Meade, Dominic Messenger, Amy Hunter, Anupama Rao, MD, Subarna Chakravorty, Rachel Wearmouth, Anju Chalin, Kristina Staley, Sheela Upadhyaya, Irene Roberts, MD, Noemi Roy, MBBCH, MD

Blood (2018) 132 (Supplement 1): 5876.

https://doi.org/10.1182/blood-2018-99-115404

Published: 2018

Journal Articles

Chronic Myeloid Leukemia Patients' Voice: Preliminary Results from the Italian Substudy of Enestpath (CAMN107AIC05), Exploring the Emotional Experience of Patients in the Context of Treatment-Free Remission

Lidia Borghi, PhD, Fausto Castagnetti, MD PhD, Franca Falzetti, MD, Massimiliano Bonifacio, MD, Enrico Capochiani, Francesca Lunghi, MD, Francesco Cavazzini, MD, Sara Galimberti, PhD MD, Claudia Minotto, Ester Maria Orlandi, MD, Simona Sica, MD, Claudia Galimberti, Jens Haenig, Sharon Supekar, Michele Baccarani, MD, Elena Vegni

Blood (2017) 130 (Supplement 1): 5654.

https://doi.org/10.1182/blood.V130.Suppl_1.5654.5654

Published: 2017

NARROW

Shared Decision Making in Cancer Treatment: Findings from a Large Survey of Lymphoma (LYM) Patients and Survivors

Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)

Voice of Cancer Patients: Patient Experience Regarding Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Voice of Cancer Patients (VoCP): Analysis of Patient Experiences and Use of Burton's Tyrosine Kinase (BTK) Inhibitors and Venetoclax in Hematological Malignancies

Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017

"in the Patients' Hands"- a Structured Survey of Patient Voices to Prioritise Research Questions in Rare Inherited Anaemias: The James Lind Alliance Priority Setting Partnership

Chronic Myeloid Leukemia Patients' Voice: Preliminary Results from the Italian Substudy of Enestpath (CAMN107AIC05), Exploring the Emotional Experience of Patients in the Context of Treatment-Free Remission

Email alerts

ASH Publications

American Society of Hematology

Shared Decision Making in Cancer Treatment: Findings from a Large Survey of Lymphoma (LYM) Patients and Survivors

Predicting Response to Hypomethylating Agents in Patients with Myelodysplastic Syndromes (MDS) Using Artificial Intelligence (AI)

Voice of Cancer Patients: Patient Experience Regarding Use of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

Voice of Cancer Patients (VoCP): Analysis of Patient Experiences and Use of Burton's Tyrosine Kinase (BTK) Inhibitors and Venetoclax in Hematological Malignancies

Patient-Reported Outcome Labeling for Malignant Hematology Drugs Approved in the United States: 2011-2017

"in the Patients' Hands"- a Structured Survey of Patient Voices to Prioritise Research Questions in Rare Inherited Anaemias: The James Lind Alliance Priority Setting Partnership

Chronic Myeloid Leukemia Patients' Voice: Preliminary Results from the Italian Substudy of Enestpath (CAMN107AIC05), Exploring the Emotional Experience of Patients in the Context of Treatment-Free Remission

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only